MedPath

Comparison of Effect of Adalimumab versus Hyaluronic Acid in Knee Osteoarthritis

Phase 4
Conditions
Health Condition 1: null- Primary Osteoarthritis of the Knee
Registration Number
CTRI/2018/09/015662
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosis of Knee OA as per 2016 ACR Revised Criteria for Early Diagnosis of Knee OA

2. Unilateral Primary OA of Grade 2 or Grade 3 on Kellgren Lawrence Scale

3. Pain Score >4 on VAS( Visual Analogue Scale) within the past one month

4. Lack of efficacy of previous treatment with Diclofenac at a dose of 75mg/day

Exclusion Criteria

1. Previous treatment with TNF inhibitors

2. Previous Intra - Articular treatment within 3 months

3.Previous Knee Surgery

4. History of tumor or serious Infection

5. Pregnancy

6. Lactation

7. Cognitive Impairment

8. Previous history of trauma to the knee

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Compare the Effect of a Single Ultrasound - Guided Intra - Articular Injection of Adalirec) mumab with a Single Ultrasound Guided Intra -Articular Injection of Hyaluronic Acid on Pain using VASTimepoint: 4 weeks and 12 weeks post injection
Secondary Outcome Measures
NameTimeMethod
To Compare the Effect of a Single Ultrasound - Guided Intra - Articular Injection of Adalimumab with a Single Ultrasound Guided Intra -Articular Injection of Hyaluronic Acid on Pain, other Symptoms, Function in Daily Living(ADL), Function in Sport and Recreation(Sport/Rec) using KOOS ScaleTimepoint: 4 weeks and 12 weeks post injection
© Copyright 2025. All Rights Reserved by MedPath